SLRX - Salarius Pharmaceuticals, Inc.
0.7318
0.015 2.050%
Share volume: 44,353
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.72
0.02
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-09-2024 | 11-14-2024 | 03-21-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 1.772 M | 1.468 M | 1.006 M | 1.489 M | |
| Selling general and admin | 1.529 M | 1.253 M | 869.237 K | 1.313 M | |
| Research and development | 243.002 K | 214.447 K | 137.234 K | 175.344 K | |
| Total expenses | 1.772 M | 1.468 M | 1.006 M | 1.489 M | |
| -17.17% | -31.42% | 47.91% | |||
| Operating income | -1.772 M | -1.468 M | -1.006 M | -1.489 M | |
| Ebit | -1.772 M | -1.468 M | -1.006 M | -1.489 M | |
| Pretax income | -1.715 M | -1.424 M | -972.121 K | -1.464 M | |
| -16.96% | -31.75% | 50.59% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.715 M | -1.424 M | -972.121 K | -1.464 M | |
| 16.96% | 31.75% | -50.59% |
